What is sclerotherapy and how does it work?
Sclerotherapy involves injecting a solution into a targeted vein that causes irritation of the wall lining the vein. This leads to the sealing off and eventual absorption of the treated vein. Sclerotherapy remains the “gold standard” treatment for unwanted small varicose veins (reticular veins) and tiny superficial veins (spider telangectasias) of the leg.
Which sclerosing solution is used at Skinstyle?
We use Asclera© (polidochanol), the newest FDA-approved product on the market. Research has shown Asclera©to be the most effective and safest sclerosing agent to date.
How many treatment sessions are necessary?
Generally speaking, most patients will require 3-6 treatments spaced ~2-3 months apart for optimal results, however this is dependent on the extent and type of veins being treated and individual response to treatment. Once an acceptable clearance of veins has been achieved, periodic maintenance treatments may be needed if new vein formation occurs in treated areas.
What can I expect during treatment?
The procedure takes on average about 30 minutes to perform. The skin is cleansed with alcohol and then tiny needles are used to inject the sclerosing solution into the targeted varicose veins, spider telangectasias, and reticular veins. With the intrinsic anesthetic property of Asclera’s active metabolite, the treatment is very comfortable.
What can I expect post-treatment?
We recommend bringing your medical grade compression stockings with you to your treatment. These will be applied after treatment is completed because this has been shown to decrease the incidence of side effects and enhance the clearance of treated veins. Compression stockings should be worn as much as possible over the next 7 days.
Are there potential side effects?
Side effects are mild in nature and if they do occur, resolve within days to weeks. The most common side effects include temporary itching, pain, swelling, and/or bruising, transient brown patches (hyperpigmentation), and new vein formation at the treatment site. Of note, when evaluated in clinical trials, Asclera© had a decreased incidence of side effects such as post-treatment hyperpigmentation and breakdown (ulceration) of skin when compared with other sclerosing agents.